NR4A1 and diabetes mellitus: Supporting evidence includes an increased susceptibility in NR4A1 deficient mice for experimental autoimmune encephalomyelitis (EAE; 2D2 transgenic TCR model), allergic contact dermatitis, collagen-induced arthritis (69), and diabetes (19).